Invea Therapeutics, Inc. is a clinical-stage biotechnology company expediting the discovery of transformational therapeutics for inflammatory gastrointestinal and hepatobiliary disorders. The Company is harnessing the power of artificial intelligence to decode innate immunity, inflammasome biology, and neuroinflammation via the gut-brain axis to increase the probability of clinical success. Clinical-stage biotech harnessing AI...
Invea Therapeutics, Inc. is a clinical-stage biotechnology company expediting the discovery of transformational therapeutics for inflammatory gastrointestinal and hepatobiliary disorders. The Company is harnessing the power of artificial intelligence to decode innate immunity, inflammasome biology, and neuroinflammation via the gut-brain axis to increase the probability of clinical success. Clinical-stage biotech harnessing AI and machine learning to decode innate immunity, inflammasome biology, and neuroinflammation via the Gut-Brain Axis (GBA) to identify, de-risk, and prioritize therapeutic programs.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.